Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 15, 2023

BUY
$23.68 - $38.51 $1.26 Million - $2.05 Million
53,269 Added 431.75%
65,607 $1.67 Million
Q4 2022

Feb 09, 2023

SELL
$28.0 - $40.56 $4,480 - $6,489
-160 Reduced 1.28%
12,338 $500,000
Q3 2022

Nov 14, 2022

BUY
$29.63 - $48.31 $370,315 - $603,778
12,498 New
12,498 $413,000
Q2 2022

Aug 12, 2022

SELL
$27.79 - $50.61 $265,700 - $483,882
-9,561 Closed
0 $0
Q1 2022

May 13, 2022

BUY
$39.62 - $69.97 $378,806 - $668,983
9,561 New
9,561 $440,000
Q4 2021

Feb 08, 2022

SELL
$58.09 - $82.51 $1.67 Million - $2.37 Million
-28,754 Closed
0 $0
Q3 2021

Nov 15, 2021

BUY
$58.38 - $84.96 $1.68 Million - $2.44 Million
28,754 New
28,754 $1.8 Million
Q2 2021

Aug 16, 2021

SELL
$62.15 - $90.32 $2.16 Million - $3.14 Million
-34,758 Closed
0 $0
Q1 2021

May 14, 2021

BUY
$61.35 - $90.47 $587,487 - $866,340
9,576 Added 38.03%
34,758 $2.31 Million
Q4 2020

Feb 02, 2021

SELL
$43.82 - $85.37 $1.87 Million - $3.64 Million
-42,692 Reduced 62.9%
25,182 $1.93 Million
Q3 2020

Nov 05, 2020

SELL
$33.21 - $51.27 $300,849 - $464,454
-9,059 Reduced 11.78%
67,874 $2.92 Million
Q2 2020

Jul 22, 2020

SELL
$26.12 - $43.27 $282,957 - $468,743
-10,833 Reduced 12.34%
76,933 $3.32 Million
Q1 2020

May 06, 2020

SELL
$20.56 - $63.12 $2.36 Million - $7.24 Million
-114,676 Reduced 56.65%
87,766 $2.53 Million
Q4 2019

Feb 03, 2020

BUY
$28.14 - $73.01 $1.71 Million - $4.44 Million
60,856 Added 42.98%
202,442 $12.8 Million
Q3 2019

Nov 04, 2019

SELL
$26.26 - $34.86 $835,777 - $1.11 Million
-31,827 Reduced 18.35%
141,586 $3.99 Million
Q2 2019

Jul 30, 2019

BUY
$17.43 - $28.82 $2.5 Million - $4.14 Million
143,632 Added 482.29%
173,413 $4.6 Million
Q1 2019

May 09, 2019

SELL
$12.05 - $20.18 $1.79 Million - $3.01 Million
-148,939 Reduced 83.34%
29,781 $546,000
Q4 2018

Feb 07, 2019

BUY
$10.74 - $19.7 $1.92 Million - $3.52 Million
178,720 New
178,720 $2.22 Million

Others Institutions Holding ARWR

About ARROWHEAD PHARMACEUTICALS, INC.


  • Ticker ARWR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 105,849,000
  • Market Cap $2.01B
  • Description
  • Arrowhead Pharmaceuticals, Inc. develops medicines for the treatment of intractable diseases in the United States. The company's products in pipeline includes ARO-AAT, a RNA interference (RNAi) therapeutic candidate that is in Phase II clinical trial for the treatment of liver diseases associated with alpha-1 antitrypsin deficiency; ARO-APOC3, w...
More about ARWR
Track This Portfolio

Track First Trust Advisors LP Portfolio

Follow First Trust Advisors LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of First Trust Advisors LP, based on Form 13F filings with the SEC.

News

Stay updated on First Trust Advisors LP with notifications on news.